The role of electronic leaflets in improving access to medication-related information
DOI:
https://doi.org/10.1558/cam.20418Keywords:
electronic leaflet, medication use, patient communication, patient counselling, patient information leafletAbstract
Background: Language discrepancies may create barriers to healthcare, compromise the quality of care and worsen health outcomes. This study explored what European countries currently do to ensure that foreign patients receive sufficient information about their medications if they do not understand the country’s national language.
Methods: A questionnaire was distributed to the delegates of two Council of Europe committees. The recipients were asked to provide insights on how their country facilitates access to the necessary product information when patients do not understand the national language.
Results: Seventeen out of 39 delegates completed the questionnaire. The majority of the respondents indicated that all healthcare professionals experience difficulties in providing guidance and advice to foreign patients. The results also showed that different methods are used nationally to present the necessary information to foreigners. Finally, the observations from this survey suggested that electronic leaflets in the patient’s primary language could be a valuable option to improve access to medication-related information.
Conclusions: Healthcare professionals seem to encounter challenges in providing foreign patients with information associated with medication use. Electronic leaflets can be one of the tools for improving communication between these patients and healthcare professionals to ensure that medicines are used safely and effectively.
References
Askehave, Inger and Karen Korning Zethsen (2014) A comparative analysis of the lay-friendliness of Danish EU patient information leaflets from 2000 to 2012. Communication and Medicine 11 (3): 209–222. https://doi.org/10.1558/cam.v11i3.20700
Bowen, Sarah (2001) Language barriers in access to health care. Online: https://www.canada.ca/content/dam/hc-sc/migration/hc-sc/hcs-sss/alt_formats/hpb-dgps/pdf/pubs/2001-lang-acces/2001-lang-acces-eng.pdf
Brown, Marie T. and Jennifer K. Bussel (2011) Medication adherence: WHO cares? Mayo Clinic Proceedings 86 (4): 304–314. https://doi.org/10.4065/mcp.2010.0575
Clerehan, Rosemary, Di Hirsh and Rachelle Buchbinder (2009) Medication information leaflets for patients: The further validation of an analytic linguistic framework. Communication & Medicine 6 (2): 117–127. https://doi.org/10.1558/cam.v6i2.117
College ter Beoordeling van Geneesmiddelen [Medicines Evaluation Board, Netherlands] (2020) Medicijn in het kort. Online: https://www.cbg-meb.nl/onderwerpen/medicijninformatie-medicijn-in-het-kort
Elliott, Rachel Ann, Elizabeth Camacho, Dina Jankovic, Mark J. Sculpher and Rita Faria (2020) Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Quality and Safety 30 (2): 96–105. https://doi.org/10.1136/bmjqs-2019-010206
European Association of Hospital Pharmacists (2021) The Future Potential of Electronic Product Information (ePI). Online: https://www.eahp.eu/sites/default/files/eahp_survey_report_the_future_potential_of_electronic_product_information.pdf
European Commission (2001) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Communities 28 November, L 311: 67–128. Online: https://cam-europe.eu/wp-content/uploads/2018/10/Directive_2001-83-EC-2.pdf
European Directorate for the Quality of Medicines and HealthCare (EDQM), Council of Europe (n.d.1). Website: http://www.edqm.eu
European Directorate for the Quality of Medicines and HealthCare (EDQM), Council of Europe (n.d.2) European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH). https://go.edqm.eu/CDPPH
European Directorate for the Quality of Medicines and HealthCare (EDQM), Council of Europe (n.d.3) Committee of Experts on Quality and Safety Standards in Pharmaceutical Practices and Pharmaceutical Care (CD-P-PH/PC). Online: https://www.edqm.eu/en/pharmaceutical-practices-and-pharmaceutical-care
European Medicines Agency (EMA) (2018) EU Telematics Management Board (EU TMB) – Terms of reference. Online: https://www.ema.europa.eu/en/documents/other/european-union-telematics-management-board-terms-reference_en.pdf
European Medicines Agency (EMA) (2020) Electronic product information for human medicines in the European Union – Key principles. Online: https://www.ema.europa.eu/en/electronic-product-information-human-medicines-european-union-key-principles
European Union (2011) Directive 2011/62/EU of the European Parliament and of the Council of 8 June 2011 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use, as regards the prevention of the entry into the legal supply chain of falsified medicinal products. Official Journal of the European Union, 1 July, L 174: 74–87. Online: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:174:0074:0087:EN:PDF
Fage-Butler, Antoinette (2013) Improving patient information leaflets: Developing and applying an evaluative model of patient-centredness for text. Communication & Medicine 10 (2): 105–115. https://doi.org/10.1558/cam.v10i2.105
Federal Agency for Medicines and Health Products (2019) Is the electronic patient information leaflet just as effective as the paper version? E-PIL pilot project evaluation. Website, 18 July. Online: https://www.famhp.be/en/news/is_the_electronic_patient_information_leaflet_just_as_effective_as_the_paper_version_e_pil
Hammar, Tora, Anna-Lena Nilsson and Bo Hovstadius (2016) Patients’ views on electronic patient information leaflets. Pharmacy Practice (Granada) 14 (2): Article 702. https://doi.org/10.18549/PharmPract.2016.02.702
Hamrosi, Kim K., David K. Raynor and Parisa Aslani (2014) Pharmacist, general practitioner and consumer use of written medicine information in Australia: Are they on the same page? Research in Social and Administrative Pharmacy 10 (4): 656–668. https://doi.org/10.1016/j.sapharm.2013.10.002
Institute of Medicine (US), Committee on Quality of Health Care in America (2000) To Err is Human: Building a Safer Health System Washington, DC: National Academies Press. Online: http://www.ncbi.nlm.nih.gov/books/NBK225182/
Koo, Michelle, Ines Krass and Parisa Aslani (2002) Consumer opinions on medicines information and factors affecting its use – An Australian experience. International Journal of Pharmacy Practice 10 (2): 107–114. https://doi.org/10.1111/j.2042-7174.2002.tb00595.x
Meuter, Renata F., Cindy Gallois, Norman S. Segalowitz, Andrew G. Ryder and Julia Hocking (2015) Overcoming language barriers in healthcare: A protocol for investigating safe and effective communication when patients or clinicians use a second language. BMC Health Services Research 15: Article 371. https://doi.org/10.1186/s12913-015-1024-8
Pines, Amos (2015) Patient information leaflets: Friend or foe? Climacteric 18 (5): 663–665. https://doi.org/10.3109/13697137.2015.1007697
Pires, Carla, Marina Vigário and Afonso Cavaco (2015) Readability of medicinal package leaflets: A systematic review. Revista de Saúde Pública 49: Article 4. https://doi.org/10.1590/S0034-8910.2015049005559
Regenstein, Marsha, Ellie Andres, Dylan Nelson, Stephanie David, Ruth Lopert and Richard Katz (2012) Medication information for patients with limited English proficiency: Lessons from the European Union. The Journal of Law, Medicine and Ethics 40 (4): 1025–1033. https://doi.org/10.1111/j.1748-720X.2012.00729.x
Van Dijk, Liset, Susana Patrício Monteiro, Marcia Vervloet, Jolanda de Bie and Theo D.K. Raynor (2014) Study on the Package Leaflets and the Summaries of Product Characteristics of Medicinal Products for Human Use. No location: European Union. Online: https://health.ec.europa.eu/system/files/2016-11/pil_s_0.pdf
Walsh, Elaine K., Christina Raae Hansen, Laura J. Sahm, Patricia M. Kearney, Edel Doherty and Colin P. Bradley (2017) Economic impact of medication error: A systematic review. Pharmacoepidemiology and Drug Safety 26 (5): 481–497. https://doi.org/10.1002/pds.4188
Weiss, Linda, Maya Scherer, Tongtan Chantarat, Oshiro Theo, Padgen Patrick, Jose Pagan, Peri Rosenfeld and H. Shonna Yin (2019) Assessing the impact of language access regulations on the provision of pharmacy services. Journal of Urban Health 96 (4): 644–651. https://doi.org/10.1007/s11524-018-0240-z
Young, Amber, June Tordoff and Alesha Smith (2017) ‘What do patients want?’ Tailoring medicines information to meet patients’ needs. Research in Social and Administrative Pharmacy 13 (6): 1186–1190. https://doi.org/10.1016/j.sapharm.2016.10.006
Published
Issue
Section
License
copyright Equinox Publishing Ltd.
